You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvanted inactivated vaccine

Showing 1 - 25 of 8,542
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults

Recruiting
  • Influenza
  • +2 more
  • Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
  • High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Sep 1, 2023

Rabies, Prevention Trial (PIKA-adjuvanted inactivated rabies vaccine, Rabipur)

Not yet recruiting
  • Rabies
  • Prevention
  • PIKA-adjuvanted inactivated rabies vaccine
  • Rabipur
  • (no location specified)
Dec 28, 2022

Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine

Recruiting
  • Poliomyelitis
  • SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Dec 24, 2022

Pain, Quality of Life, Injection Site Reaction Trial in Durham (FLUAD® Quadrivalent, Fluzone® HD Quadrivalent, SHINGRIX®)

Recruiting
  • Pain
  • +3 more
  • FLUAD® Quadrivalent
  • +2 more
  • Durham, North Carolina
    Duke University
Jan 19, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)

Active, not recruiting
  • Influenza
  • +3 more
  • Fluzone® quadrivalent
  • +5 more
  • Stanford, California
    Stanford LPCH Vaccine Program
Dec 12, 2022

Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)

Not yet recruiting
  • Influenza, Human
  • aQIV
  • QIV
  • Batumi, Georgia
  • +16 more
Oct 11, 2023

Zika Virus Infection Trial in Ponce (Placebo, Zika Virus Purified Inactivated Vaccine (ZPIV))

Completed
  • Zika Virus Infection
  • Placebo
  • Zika Virus Purified Inactivated Vaccine (ZPIV)
  • Ponce, Puerto Rico
    Ponce School of Medicine CAIMED Center
Apr 5, 2022

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

SARS CoV 2 Infection, Influenza, Human Trial in Spain (BIMERVAX, SIIV)

Not yet recruiting
  • SARS CoV 2 Infection
  • Influenza, Human
  • BIMERVAX
  • SIIV
  • Santiago De Compostela, A Coruña, Spain
  • +7 more
Aug 8, 2023

Influenza, Human Trial in Hong Kong (Standard inactivated influenza vaccine (NH formulation), MF 59 adjuvanted inactivated

Active, not recruiting
  • Influenza, Human
  • Standard inactivated influenza vaccine (NH formulation)
  • +3 more
  • Hong Kong, China
    The University of Hong Kong
Sep 24, 2021

Influenza Trial in Saint Louis (mRNA-1010, Egg-based Quadrivalent Influenza Vaccine, Adjuvanted Quadrivalent Influenza Vaccine)

Recruiting
  • Influenza
  • mRNA-1010
  • +3 more
  • Saint Louis, Missouri
    Washington University in St. Louis
Nov 4, 2022

Influenza Trial in Canada (aTIV Primer, QIV Primer, aTIV Booster)

Completed
  • Influenza
  • aTIV Primer
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 28, 2022

Influenza Trial in Canada, United States (High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 µg (split-virion, inactivated),

Completed
Has Results
  • Influenza
  • High-Dose Quadrivalent Influenza Vaccine (QIV-HD) 30 μg (split-virion, inactivated)
  • +4 more
  • San Diego, California
  • +15 more
Mar 24, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU vaccine
  • Edegem, Belgium
  • +33 more
Dec 7, 2022

Influenza, Human Trial in Estonia, Germany, United States (aQIV, Comparator QIV)

Active, not recruiting
  • Influenza, Human
  • aQIV
  • Comparator QIV
  • Mobile, Alabama
  • +28 more
Jul 26, 2022

Enterovirus Infections Trial in Taiwan, Vietnam (EV71 vaccine, Placebo)

Enrolling by invitation
  • Enterovirus Infections
  • EV71 vaccine
  • Placebo
  • Changhua, Taiwan
  • +7 more
Dec 5, 2021

Seasonal Influenza, Influenza, Influenza Due to Unspecified Influenza Virus Trial in Antwerpen, Hasselt (MF59C.1-adjuvanted

Completed
Has Results
  • Seasonal Influenza
  • +3 more
  • MF59C.1-adjuvanted subunit influenza vaccine
  • Sub unit, Inactivated, Influenza vaccine
  • Antwerpen, Belgium
  • +1 more
Apr 14, 2021

Influenza, Human Trial in United States (Investigational aIIV4c, IIV4c type 1, aIIV4)

Completed
  • Influenza
  • Human
  • Investigational aIIV4c
  • +3 more
  • Mobile, Alabama
  • +20 more
Mar 15, 2022

Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
  • Amsterdam, Netherlands
    The Amsterdam University Medical Centers
Aug 2, 2023

Pain, Quality of Life, Injection Site Reaction Trial in United States (FLUAD®, Fluzone® High-Dose)

Completed
Has Results
  • Pain
  • +4 more
  • FLUAD®
  • Fluzone® High-Dose
  • Atlanta, Georgia
  • +3 more
Mar 4, 2021

Influenza Trial in Worldwide (aQII-1, aQII-3 Investigational, aQII-6 Investigational)

Completed
  • Influenza
  • Bruce, Canberra, Australia
  • +29 more
Aug 16, 2022

Influenza, Vaccine Trial in Durham, Cincinnati (cH8/1N1 LAIV, AS03-adjuvanted cH5/1N1 IIV, cH5/1N1 IIV)

Completed
Has Results
  • Influenza
  • Vaccine
  • cH8/1N1 LAIV
  • +5 more
  • Durham, North Carolina
  • +1 more
Feb 1, 2021

Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

Not yet recruiting
  • Hiv
  • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
  • (no location specified)
May 8, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023